Zusammenfassung
Die Hämostase ist ein wichtiger Bestandteil der Wirtsabwehr und Wundheilung. Die Interaktion zwischen Hämostase und Inflammation ist erst in den letzten Jahrzehnten ins Zentrum der Forschung gerückt. Im Mittelpunkt dieser Untersuchungen steht das Thrombin, das als das zentrale Enzym des Hämostasesystems gilt. Immunmodulatorische Therapiestrategien, wie die supraphysiologischen Gaben von Antithrombin und aktiviertem Protein C bei Sepsis, basierten auf den Grundlagen der wissenschaftlichen Untersuchungen über Thrombingenerierung und deren Rolle in der inflammatorischen Reaktion. Die komplexe Funktion des Thrombins ist allerdings noch nicht vollständig geklärt worden.
Abstract
Hemostasis is an important component of host defense and wound healing. During the last few decades, the interaction between hemostasis and inflammation has moved into the center of research. Thrombin, which is considered the central enzyme of the hemostatic system, plays a key role in these investigations. Immune modulatory treatment strategies, such as the supraphysiological doses of antithrombin and activated protein C in sepsis, were based on scientific investigations of thrombin generation and its role in inflammatory reactions. However, the complex function of thrombin has not yet been fully elucidated.
Literatur
Altieri DC (1995) Proteases and protease receptors in modulation of leukocyte effector functions. J Leukoc Biol 58:120–127
Amara U, Flierl MA, Rittirsch D et al (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185:5628–5636
Bevilacqua MP, Pober JS, Majeau GR et al (1984) Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160:618–623
Chambers RC, Leoni P, Blanc-Brude OP et al (2000) Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 275:35584–35591
Chen D, Dorling A (2009) Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost 7(Suppl 1):122–126
Collins PW, Macchiavello LI, Lewis SJ et al (2006) Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 135:220–227
Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258–264
Esmon CT (2003) The protein C pathway. Chest 124:26S–32S
Hemker HC, Giesen PL, Ramjee M et al (2000) The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 83:589–591
Hemker HC, Wielders S, Kessels H, Béguin S (1993) Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 71:617–624
Hoffman M, Church FC (1993) Response of blood leukocytes to thrombin receptor peptides. J Leukoc Biol 54:145–151
Hoffman M, Monroe DM 3rd (2001) A cell-based model of hemostasis. Thromb Haemost 85:958–965
Jones A, Geczy CL (1990) Thrombin and factor Xa enhance the production of interleukin-1. Immunology 71:236–241
Levi M, Jonge E de, Meijers J (2002) The diagnosis of disseminated intravascular coagulation. Blood Rev 16:217–223
Levi M, Poll T van der, Schultz M (2011) Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol DOI 10.1007/s00281-011-0283-7
Madoiwa S, Tanaka H, Nagahama Y et al (2011) Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation. Thromb Res 127:349–355
Mann KG, Brummel K, Butenas S (2003) What is all that thrombin for? J Thromb Haemost 1:1504–1514
Mann KG, Butenas S, Brummel K (2003) The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 23:17–25
Massberg S, Grahl L, Bruehl ML von et al (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887–896
Minami T, Sugiyama A, Wu SQ et al (2004) Thrombin and phenotypic modulation of the endothelium. Arterioscler Thromb Vasc Biol 24:41–53
Naldini A, Carney DH, Bocci V et al (1993) Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol 147:367–377
Nogami K, Ogiwara K, Matsumoto T et al (2011) Mechanisms of human neutrophil elastase-catalysed inactivation of factor VIII (a). Thromb Haemost 105:968–980
Oliver JA, Monroe DM, Roberts HR, Hoffman M (1999) Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 19:170–177
Papareddy P, Rydengard V, Pasupuleti M et al (2010) Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog 6:e1000857
Petros S, Kliem P, Siegemund T, Siegemund R (2011) Thrombin generation in severe sepsis. Thromb Res. doi:10.1016/j.thromres. 2011.08.04 (epub ahead of print)
Schouten M, Wiersinga WJ, Levi M, Poll T van der (2008) Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 83:536–545
Interessenkonflikt
Der Erstautor erhielt von CSL Behring eine finanzielle Unterstützung für ein unabhängiges wissenschaftliches Projekt.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petros, S., Siegemund, R. Thrombingenerierung bei kritischer Erkrankung. Med Klin 106, 166–170 (2011). https://doi.org/10.1007/s00063-011-0013-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-011-0013-x